+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cytomegalovirus Tests Market by Product, Test Type, Application, End User, Sample Type - Global Forecast to 2030- Product Image
Cytomegalovirus Tests Market by Product, Test Type, Application, End User, Sample Type - Global Forecast to 2030- Product Image
Sale

Cytomegalovirus Tests Market by Product, Test Type, Application, End User, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968363
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cytomegalovirus tests market is transforming as healthcare environments demand advanced, sensitive diagnostics tailored to immunocompromised and at-risk populations. Innovative platforms and strategic responses to policy changes are driving competitive differentiation, while evolving segmentation strategies help key stakeholders align investments and maximize value in diverse geographies.

Market Snapshot: Cytomegalovirus Tests Market Size & Growth Trends

In recent years, the cytomegalovirus tests market has experienced measured expansion, underpinned by continual advances in molecular diagnostic techniques and a heightened clinical focus on early detection. Market growth is propelled by increased adoption of sensitive, rapid screening platforms, a diverse array of assay types, and regional healthcare policies that encourage comprehensive monitoring. The influx of new entrants alongside long-standing leaders has stimulated product innovation and enhanced choice for laboratories, clinics, and research institutions. Strong demand persists across regions, supported by large-scale screening initiatives, investment in maternal and transplantation health, and robust infrastructure development.

Scope & Segmentation: Complete Coverage for Strategic Planning

  • Product Categories: Antigen detection tests (immunofluorescence assays, lateral flow assays), nucleic acid amplification tests (digital polymerase chain reaction, isothermal amplification, real time polymerase chain reaction), and serological assays (chemiluminescent immunoassay, enzyme linked immunosorbent assay, lateral flow immunoassay).
  • Test Types: Qualitative and quantitative tests supporting diverse diagnostic needs.
  • Applications: Diagnostic confirmation, donor screening, prenatal testing, and wide-scale screening efforts for epidemiological surveillance and risk management.
  • End Users: Clinics, diagnostic laboratories, hospitals, and research institutes, each with unique operational and strategic priorities.
  • Sample Types: Analysis across saliva, tissue, urine, and whole blood matrices, enabling broad adoption and expanding diagnostic reach.
  • Geographical Coverage:
    • Americas: United States (including key states such as California and Texas), Canada, Mexico, Brazil, Argentina.
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, nations in the GCC, South Africa, and other major territories.
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Leading Companies Analyzed: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Qiagen N.V., bioMérieux SA, Hologic, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, PerkinElmer, Inc.

Key Takeaways for Senior Decision-Makers

  • Expanding diagnostic toolkits leverage both molecular and immunological technologies, accommodating variable clinical workflows and enabling risk stratification in vulnerable groups.
  • Multiplex molecular and isothermal platforms are increasingly significant, delivering heightened sensitivity and supporting deployment in resource-constrained settings that lack advanced laboratory infrastructure.
  • Robust segmentation—by product type, modality, and application—supports targeted development, marketing strategies, and risk diversification across healthcare environments.
  • Regional markets differ in adoption speed, with North America benefiting from strong reimbursement, Europe from regulatory harmonization, and Asia-Pacific from major localization initiatives and public health investments.
  • Dynamic competitive landscape sees established and emerging players pursuing collaborations, co-development agreements, and tailored pricing models to address both laboratory and point-of-care needs.

Tariff Impact: Navigating Policy Changes in the Cytomegalovirus Tests Market

The introduction of new tariffs on imported reagents and instruments has increased cost sensitivity and supply chain complexity within the United States diagnostics ecosystem. Many suppliers are localizing production, adjusting pricing, and forming strategic partnerships to mitigate tariff exposure. These actions may affect procurement cycles for laboratories and research organizations and highlight the importance of resilient sourcing strategies to maintain reliable diagnostic access during periods of policy-driven volatility.

Methodology & Data Sources

This report applies a rigorous blend of secondary and primary research, including detailed industry review, regulatory filings, and input from industry experts such as diagnostic executives and supply chain specialists. Iterative validation ensures both empirical evidence and practical perspectives underpin all findings, delivering credible, actionable market intelligence for cytomegalovirus testing.

Why This Report Matters

  • Delivers a comprehensive examination of segmentation strategies, helping leaders allocate resources and tailor product portfolios for optimal market impact.
  • Informs procurement, investment, and partnership decisions by clarifying technology, regional, and regulatory developments that shape the current and future diagnostics landscape.

Conclusion

The cytomegalovirus tests market is evolving in response to new technologies, policy shifts, and regional dynamics. Stakeholders equipped with timely insights and robust strategies will be best positioned to capitalize on emerging opportunities and navigate ongoing change in this critical diagnostic domain.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cytomegalovirus Tests Market, by Product
8.1. Introduction
8.2. Antigen Detection Test
8.2.1. Immunofluorescence Assay
8.2.2. Lateral Flow Assay
8.3. Nucleic Acid Amplification Test
8.3.1. Digital Polymerase Chain Reaction
8.3.2. Isothermal Amplification
8.3.3. Real Time Polymerase Chain Reaction
8.4. Serological Assay
8.4.1. Chemiluminescent Immunoassay
8.4.2. Enzyme Linked Immunosorbent Assay
8.4.3. Lateral Flow Immunoassay
9. Cytomegalovirus Tests Market, by Test Type
9.1. Introduction
9.2. Qualitative
9.3. Quantitative
10. Cytomegalovirus Tests Market, by Application
10.1. Introduction
10.2. Diagnostic
10.3. Donor Screening
10.4. Prenatal Testing
10.5. Screening
11. Cytomegalovirus Tests Market, by End User
11.1. Introduction
11.2. Clinic
11.3. Diagnostic Laboratory
11.4. Hospital
11.5. Research Institute
12. Cytomegalovirus Tests Market, by Sample Type
12.1. Introduction
12.2. Saliva
12.3. Tissue
12.4. Urine
12.5. Whole Blood
13. Americas Cytomegalovirus Tests Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cytomegalovirus Tests Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cytomegalovirus Tests Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Qiagen N.V.
16.3.4. bioMérieux SA
16.3.5. Hologic, Inc.
16.3.6. Siemens Healthineers AG
16.3.7. Thermo Fisher Scientific Inc.
16.3.8. Danaher Corporation
16.3.9. Becton, Dickinson and Company
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CYTOMEGALOVIRUS TESTS MARKET MULTI-CURRENCY
FIGURE 2. CYTOMEGALOVIRUS TESTS MARKET MULTI-LANGUAGE
FIGURE 3. CYTOMEGALOVIRUS TESTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CYTOMEGALOVIRUS TESTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CYTOMEGALOVIRUS TESTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CYTOMEGALOVIRUS TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DONOR SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 59. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 60. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 61. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 132. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 133. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 134. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 188. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 189. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 190. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. QATAR CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 250. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 252. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 253. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 254. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 255. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. POLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 277. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 278. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 279. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 280. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 285. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 286. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 287. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 288. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. INDIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2030 (USD MILLION)
TABLE 327. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 328. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. THAILAND CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cytomegalovirus Tests market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Qiagen N.V.
  • bioMérieux SA
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 731.24 Million
Forecasted Market Value ( USD ) by 2030 $ 1020 Million
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

2024-2029 Global CMV Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - Product Image

2024-2029 Global CMV Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
2024-2028 Global Cytomegalovirus (CMV) Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Cytomegalovirus (CMV) Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Cytomegalovirus Treatment Market by Treatment Type, Route of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030 - Product Image

Cytomegalovirus Treatment Market by Treatment Type, Route of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Cytomegalovirus (CMV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

Cytomegalovirus (CMV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • 52 Pages
  • Global
From
Cytomegalovirus Treatment Drugs Market by Drug Type, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Cytomegalovirus Treatment Drugs Market by Drug Type, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From

About the Cytomegalovirus Test Market

The Cytomegalovirus Test is a type of infectious disease test used to detect the presence of the cytomegalovirus (CMV) in a patient's body. CMV is a common virus that can cause serious health problems in people with weakened immune systems. The test is used to diagnose CMV infection, monitor the progression of the infection, and determine the effectiveness of treatment. It is also used to screen pregnant women for CMV infection, as it can cause birth defects if the mother is infected. The Cytomegalovirus Test market is composed of a variety of diagnostic companies that offer tests for CMV. These companies provide a range of products, including ELISA kits, PCR kits, and rapid tests. Some of the companies in the market include Abbott, Bio-Rad, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.